Kainos Medicine (284620)

Currency in KRW
1,006
-1(-0.10%)
Closed·
284620 Scorecard
Full Analysis
Stock has taken a big hit over the last week
284620 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9911,016
52 wk Range
9756,000
Key Statistics
Bid/Ask
1,003.00 / 1,006.00
Prev. Close
1,007
Open
1,005
Day's Range
991-1,016
52 wk Range
975-6,000
Volume
116.25K
Average Volume (3m)
102.97K
1-Year Change
-76.81%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
284620 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Kainos Medicine Company Profile

Kainos Medicine, Inc. engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally. The company’s product pipeline includes KM-819, which is completed Phase I clinical study for the treatment of Parkinson’s disease; and KM023, a novel non-nucleoside reverse transcriptase inhibitor that is in Phase III clinical study to treat HIV/AIDS. It is developing anticancer agents, including DNA methyltransferase inhibitor; gene target anti-cancer agent; and Ara-C, a cytotoxic anti-cancer agent to treat acute myeloid leukemia, as well as small molecule immuno-oncology drugs that modulate anti-cancer abilities of immune cells. In addition, the company is involved in the discovery of a Hepatitis B drug. It has a collaboration agreement with Emmaus Life Sciences, Inc. for the preclinical development of IRAK4 inhibitor as potential anti-cancer drug. The company was founded in 2007 and is headquartered in Seongnam-si, South Korea.

Compare 284620 to Peers and Sector

Metrics to compare
284620
Peers
Sector
Relationship
P/E Ratio
0.0x−4.8x−0.5x
PEG Ratio
0.00−0.090.00
Price/Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x19.6x3.2x
Upside (Analyst Target)
0.0%25.1%42.0%
Fair Value Upside
Unlock−2.0%6.6%Unlock

Earnings

Latest Release
May 12, 2023
EPS / Forecast
-122.48 / --
Revenue / Forecast
70.55M / --
EPS Revisions
Last 90 days

284620 Income Statement

FAQ

What Stock Exchange Does Kainos Med Trade On?

Kainos Med is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Kainos Med?

The stock symbol for Kainos Med is "284620."

What Is the Kainos Med Market Cap?

As of today, Kainos Med market cap is 33.32B.

What Is Kainos Med's Earnings Per Share (TTM)?

The Kainos Med EPS (TTM) is 6.18.

From a Technical Analysis Perspective, Is 284620 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Kainos Med Stock Split?

Kainos Med has split 1 times.

How Many Employees Does Kainos Med Have?

Kainos Med has 0 employees.

What is the current trading status of Kainos Med (284620)?

As of 30 Jul 2025, Kainos Med (284620) is trading at a price of 1,006.00, with a previous close of 1,007.00. The stock has fluctuated within a day range of 991.00 to 1,016.00, while its 52-week range spans from 975.00 to 6,000.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.